---
keywords:
  - Attention Mechanism
  - Precision-Aware Quantization
  - Drug Synergy Prediction
  - Graph Neural Network
category: cs.LG
publish_date: 2025-09-23
arxiv_id: 2505.19144
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T02:44:34.335040",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Attention Mechanism",
    "Precision-Aware Quantization",
    "Drug Synergy Prediction",
    "Graph Neural Network"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Attention Mechanism": 0.82,
    "Precision-Aware Quantization": 0.79,
    "Drug Synergy Prediction": 0.81,
    "Graph Neural Network": 0.83
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "dual-attention mechanism",
        "canonical": "Attention Mechanism",
        "aliases": [
          "dual-attention"
        ],
        "category": "specific_connectable",
        "rationale": "The dual-attention mechanism is a specific application of the broader attention mechanism, enhancing connectivity with related models.",
        "novelty_score": 0.55,
        "connectivity_score": 0.85,
        "specificity_score": 0.78,
        "link_intent_score": 0.82
      },
      {
        "surface": "Precision-Aware Quantization",
        "canonical": "Precision-Aware Quantization",
        "aliases": [
          "PAQ"
        ],
        "category": "unique_technical",
        "rationale": "This is a novel technique introduced in the paper, providing a unique approach to optimizing computational efficiency.",
        "novelty_score": 0.92,
        "connectivity_score": 0.65,
        "specificity_score": 0.88,
        "link_intent_score": 0.79
      },
      {
        "surface": "drug synergy prediction",
        "canonical": "Drug Synergy Prediction",
        "aliases": [
          "synergy prediction"
        ],
        "category": "unique_technical",
        "rationale": "The paper focuses on predicting drug synergies, a specific and novel application in computational biology.",
        "novelty_score": 0.78,
        "connectivity_score": 0.72,
        "specificity_score": 0.85,
        "link_intent_score": 0.81
      },
      {
        "surface": "graph-based approaches",
        "canonical": "Graph Neural Network",
        "aliases": [
          "graph-based methods"
        ],
        "category": "specific_connectable",
        "rationale": "Graph-based approaches are integral to the model's architecture, linking well with existing graph neural network research.",
        "novelty_score": 0.48,
        "connectivity_score": 0.88,
        "specificity_score": 0.76,
        "link_intent_score": 0.83
      }
    ],
    "ban_list_suggestions": [
      "drug combinations",
      "experimental screening",
      "computational models"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "dual-attention mechanism",
      "resolved_canonical": "Attention Mechanism",
      "decision": "linked",
      "scores": {
        "novelty": 0.55,
        "connectivity": 0.85,
        "specificity": 0.78,
        "link_intent": 0.82
      }
    },
    {
      "candidate_surface": "Precision-Aware Quantization",
      "resolved_canonical": "Precision-Aware Quantization",
      "decision": "linked",
      "scores": {
        "novelty": 0.92,
        "connectivity": 0.65,
        "specificity": 0.88,
        "link_intent": 0.79
      }
    },
    {
      "candidate_surface": "drug synergy prediction",
      "resolved_canonical": "Drug Synergy Prediction",
      "decision": "linked",
      "scores": {
        "novelty": 0.78,
        "connectivity": 0.72,
        "specificity": 0.85,
        "link_intent": 0.81
      }
    },
    {
      "candidate_surface": "graph-based approaches",
      "resolved_canonical": "Graph Neural Network",
      "decision": "linked",
      "scores": {
        "novelty": 0.48,
        "connectivity": 0.88,
        "specificity": 0.76,
        "link_intent": 0.83
      }
    }
  ]
}
-->

# DPASyn: Mechanism-Aware Drug Synergy Prediction via Dual Attention and Precision-Aware Quantization

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250923|20250923]] [[categories/cs.LG|cs.LG]]
**PDF**: [Download](https://arxiv.org/pdf/2505.19144.pdf)
**Category**: cs.LG
**Published**: 2025-09-23
**ArXiv ID**: [2505.19144](https://arxiv.org/abs/2505.19144)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-22/A Multi-Scale Graph Neural Process with Cross-Drug Co-Attention for Drug-Drug Interactions Prediction_20250922|A Multi-Scale Graph Neural Process with Cross-Drug Co-Attention for Drug-Drug Interactions Prediction]] (87.0% similar)
- [[2025-09-18/Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery_20250918|Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery]] (83.2% similar)
- [[2025-09-22/Rethinking Molecule Synthesizability with Chain-of-Reaction_20250922|Rethinking Molecule Synthesizability with Chain-of-Reaction]] (80.0% similar)
- [[2025-09-23/TF-DWGNet_ A Directed Weighted Graph Neural Network with Tensor Fusion for Multi-Omics Cancer Subtype Classification_20250923|TF-DWGNet: A Directed Weighted Graph Neural Network with Tensor Fusion for Multi-Omics Cancer Subtype Classification]] (79.8% similar)
- [[2025-09-23/Medical priority fusion_ achieving dual optimization of sensitivity and interpretability in nipt anomaly detection_20250923|Medical priority fusion: achieving dual optimization of sensitivity and interpretability in nipt anomaly detection]] (79.4% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Attention Mechanism|Attention Mechanism]], [[keywords/Graph Neural Network|Graph Neural Network]]
**âš¡ Unique Technical**: [[keywords/Precision-Aware Quantization|Precision-Aware Quantization]], [[keywords/Drug Synergy Prediction|Drug Synergy Prediction]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2505.19144v2 Announce Type: replace 
Abstract: Drug combinations are essential in cancer therapy, leveraging synergistic drug-drug interactions (DDI) to enhance efficacy and combat resistance. However, the vast combinatorial space makes experimental screening impractical, and existing computational models struggle to capture the complex, bidirectional nature of DDIs, often relying on independent drug encoding or simplistic fusion strategies that miss fine-grained inter-molecular dynamics. Moreover, state-of-the-art graph-based approaches suffer from high computational costs, limiting scalability for real-world drug discovery. To address this, we propose DPASyn, a novel drug synergy prediction framework featuring a dual-attention mechanism and Precision-Aware Quantization (PAQ). The dual-attention architecture jointly models intra-drug structures and inter-drug interactions via shared projections and cross-drug attention, enabling fine-grained, biologically plausible synergy modeling. While this enhanced expressiveness brings increased computational resource consumption, our proposed PAQ strategy complements it by dynamically optimizing numerical precision during training based on feature sensitivity-reducing memory usage by 40% and accelerating training threefold without sacrificing accuracy. With LayerNorm-stabilized residual connections for training stability, DPASyn outperforms seven state-of-the-art methods on the O'Neil dataset (13,243 combinations) and supports full-batch processing of up to 256 graphs on a single GPU, setting a new standard for efficient and expressive drug synergy prediction.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì•” ì¹˜ë£Œì—ì„œ ì•½ë¬¼ ë³‘í•©ì˜ ì‹œë„ˆì§€ íš¨ê³¼ë¥¼ ì˜ˆì¸¡í•˜ëŠ” ìƒˆë¡œìš´ í”„ë ˆì„ì›Œí¬ì¸ DPASynì„ ì œì•ˆí•©ë‹ˆë‹¤. ê¸°ì¡´ ëª¨ë¸ë“¤ì´ ë³µì¡í•œ ì•½ë¬¼ ê°„ ìƒí˜¸ì‘ìš©ì„ ì œëŒ€ë¡œ í¬ì°©í•˜ì§€ ëª»í•˜ëŠ” ë¬¸ì œë¥¼ í•´ê²°í•˜ê¸° ìœ„í•´, DPASynì€ ì´ì¤‘ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ê³¼ ì •ë°€ë„ ì¸ì‹ ì–‘ìí™”(PAQ)ë¥¼ ë„ì…í•©ë‹ˆë‹¤. ì´ì¤‘ ì£¼ì˜ êµ¬ì¡°ëŠ” ì•½ë¬¼ ë‚´ êµ¬ì¡°ì™€ ì•½ë¬¼ ê°„ ìƒí˜¸ì‘ìš©ì„ ì •ë°€í•˜ê²Œ ëª¨ë¸ë§í•˜ë©°, PAQëŠ” ë©”ëª¨ë¦¬ ì‚¬ìš©ëŸ‰ì„ 40% ì¤„ì´ê³  í•™ìŠµ ì†ë„ë¥¼ ì„¸ ë°°ë¡œ ì¦ê°€ì‹œí‚µë‹ˆë‹¤. DPASynì€ O'Neil ë°ì´í„°ì…‹ì—ì„œ ê¸°ì¡´ 7ê°€ì§€ ìµœì²¨ë‹¨ ë°©ë²•ì„ ëŠ¥ê°€í•˜ë©°, ë‹¨ì¼ GPUì—ì„œ ìµœëŒ€ 256ê°œì˜ ê·¸ë˜í”„ë¥¼ ì²˜ë¦¬í•  ìˆ˜ ìˆëŠ” íš¨ìœ¨ì„±ê³¼ í‘œí˜„ë ¥ì„ ì œê³µí•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. DPASynì€ ì´ì¤‘ ì£¼ì˜ ë©”ì»¤ë‹ˆì¦˜ê³¼ ì •ë°€ë„ ì¸ì‹ ì–‘ìí™”ë¥¼ íŠ¹ì§•ìœ¼ë¡œ í•˜ëŠ” ìƒˆë¡œìš´ ì•½ë¬¼ ì‹œë„ˆì§€ ì˜ˆì¸¡ í”„ë ˆì„ì›Œí¬ì…ë‹ˆë‹¤.
- 2. ì´ì¤‘ ì£¼ì˜ ì•„í‚¤í…ì²˜ëŠ” ì•½ë¬¼ ë‚´ êµ¬ì¡°ì™€ ì•½ë¬¼ ê°„ ìƒí˜¸ì‘ìš©ì„ ê³µë™ìœ¼ë¡œ ëª¨ë¸ë§í•˜ì—¬ ì„¸ë°€í•˜ê³  ìƒë¬¼í•™ì ìœ¼ë¡œ íƒ€ë‹¹í•œ ì‹œë„ˆì§€ ëª¨ë¸ë§ì„ ê°€ëŠ¥í•˜ê²Œ í•©ë‹ˆë‹¤.
- 3. ì •ë°€ë„ ì¸ì‹ ì–‘ìí™” ì „ëµì€ ë©”ëª¨ë¦¬ ì‚¬ìš©ëŸ‰ì„ 40% ì¤„ì´ê³  í•™ìŠµ ì†ë„ë¥¼ 3ë°° í–¥ìƒì‹œí‚¤ë©´ì„œë„ ì •í™•ë„ë¥¼ ìœ ì§€í•©ë‹ˆë‹¤.
- 4. DPASynì€ O'Neil ë°ì´í„°ì…‹ì—ì„œ 13,243ê°œì˜ ì¡°í•©ì„ ëŒ€ìƒìœ¼ë¡œ 7ê°œì˜ ìµœì‹  ë°©ë²•ì„ ëŠ¥ê°€í•˜ë©°, ë‹¨ì¼ GPUì—ì„œ ìµœëŒ€ 256ê°œì˜ ê·¸ë˜í”„ë¥¼ ì „ì²´ ë°°ì¹˜ë¡œ ì²˜ë¦¬í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.
- 5. LayerNormìœ¼ë¡œ ì•ˆì •ì„±ì„ í™•ë³´í•œ ì”ì°¨ ì—°ê²°ì„ í†µí•´ DPASynì€ íš¨ìœ¨ì ì´ê³  í‘œí˜„ë ¥ ìˆëŠ” ì•½ë¬¼ ì‹œë„ˆì§€ ì˜ˆì¸¡ì˜ ìƒˆë¡œìš´ ê¸°ì¤€ì„ ì œì‹œí•©ë‹ˆë‹¤.


---

*Generated on 2025-09-24 02:44:34*